Cargando…
Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets
Cyclotron-produced astatine-211 ((211)At) shows tremendous promise in targeted alpha therapy (TAT) applications due to its attractive half-life and its 100% α-emission from nearly simultaneous branched alpha decay. Astatine-211 is produced by alpha beam bombardment of naturally monoisotopic bismuth...
Autores principales: | O’Hara, Matthew J., Krzysko, Anthony J., Hamlin, Donald K., Li, Yawen, Dorman, Eric F., Wilbur, D. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937302/ https://www.ncbi.nlm.nih.gov/pubmed/31889075 http://dx.doi.org/10.1038/s41598-019-56272-7 |
Ejemplares similares
-
Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system
por: Li, Yawen, et al.
Publicado: (2019) -
cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies
por: Li, Yawen, et al.
Publicado: (2018) -
Development Of [(211)At]Astatine-Based Anti-CD123 Radioimmunotherapy For Acute Leukemias and Other CD123+ Malignancies
por: Laszlo, George S., et al.
Publicado: (2022) -
New neutron-rich isotopes of astatine and bismuth
por: Burke, D G, et al.
Publicado: (1989) -
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
por: Lindegren, Sture, et al.
Publicado: (2020)